HTLV-1-Related Malignant Neoplasm — Trials

HTLV-1-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

121 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: Carlos Brites
Termination share: 28.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

clinicaltrialsPublishedShowing 51–76 of 76 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01274533	Lenalidomide in HTLV-1 Adult T-Cell Leukemia	completed	Phase 2	4	Columbia UniversityOTHER	1	May 23, 2016	clinicaltrials
NCT01466881	Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma	completed	Phase 2	42	National Cancer Institute (NCI)NIH	2	Mar 10, 2016	clinicaltrials
NCT01748721